MedPath

The effect of melatonin on the side effects of methamphetamine

Phase 2
Conditions
Methamphetamine Addiction.
Other stimulant abuse
F15.1
Registration Number
IRCT20200521047533N1
Lead Sponsor
Shahroud University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
46
Inclusion Criteria

have a methamphetamine use history longer than 12 months;
Male
No history of severe Neurological disease
No history of severe Head Trauma
Do not take psychiatric drugs now

Exclusion Criteria

Having severe psychological illness
Having blood diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of percentage of circulating stem cells in the blood by measuring CD + 34 and CD45 markers. Timepoint: Pre and Post Treatment. Method of measurement: Flow cytometry.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath